---
$id: https://graph.org.ai/products/commodity/51282942
$type: Product
source: UNSPSC
code: "51282942"
title: "Rosoxacin"
class: "51282900"
classTitle: "Quinolone antibacterials"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Rosoxacin

**UNSPSC Code**: 51282942
**Class**: [Quinolone antibacterials](Quinolone antibacterials.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a quinolone antibiotic with the molecular formula C17H14N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3Y1OT3J4NW, chemically known as 3-quinolinecarboxylic acid, 1-ethyl-1,4-dihydro-4-oxo-7-(4-pyridinyl)- but generally known as rosoxacin, which bears US NIH Compound Identifier 287180. European Medicines Agency schedules Rosoxacin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10389MIG. The term ROSOXACIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules rosoxacin in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule rosoxacin under HS 29334910 and SITC 51575. As of Q4 2014, ROSOXACIN remains the US FDA Preferred Term for this commodity. Rosoxacin bears US NLM identifiers UMLS ID C0073591 and NCI Concept Code C76232. SMILES: O=C1C2C(N(CC)CC1C(=O)O)CC(CC2)C1CCNCC1.

